In particular, the panel has urged countries to use their public health agencies to inform citizens on how they can improve their lifestyle so they can live longer and healthier. In addition, the panel wrote, there is a need to develop regenerative therapies that could restore the structure and function in older youth to repair and neutralize the cellular damage that occurs with aging.The results in the aging process of social and medical costs will increase rapidly in coming decades the number of elderly increases. To avoid what he calls ‘a global crisis of aging’, the Commission recommends that the United States and other countries are collaborating on an international initiative that will result in laboratory results on aging in new types of drugs.
‘There’s this misconception that aging is something that only happens to you, such as time, and can not be affected,’ said Dr. Vijg. ‘The big surprise of recent decades is that, in many different animals, we can increase the healthy lifespan in different ways. A program to develop and test two interventions were similar in males, medically and economically.’
Now that scientists have learned a lot about aging through laboratory studies, it is time to translate these findings into drugs that can benefit from our population. This is the message delivered by a jury of 10 prominent experts, including aging January Vijg, Ph.D., president of genetics and the Lola and Saul Kramer Chair in Molecular Genetics at the Albert Einstein College of Medicine, Yeshiva University .